Italy – Administrative healthcare services – PROCEDURA APERTA PER L’AFFIDAMENTO AD UNA CONTRACT RESEARCH ORGANIZATION (CRO) DEI SERVIZI PER LA GESTIONE DELLO STUDIO CLINICO MULTICENTRICO RANDOMIZZATO: “COMBOSEQ - SEQUENCE STRATEGY OF IMMUNEONCOLOGY (IO-IO) VS IO-TYROSINE KINASE INHIBITORS (TKI) FOLLOWED BY TKI IN METASTATIC RENAL CELL CARCINOMA (MRCC): A RANDOMIZED PHASE 3 STUDY MEETURO AND FICOG TRIAL”, MEDIANTE PIATTAFORMA SINTEL
FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI
Open procedure by FONDAZIONE IRCCS ISTITUTO NAZIONALE DEI TUMORI, estimated at €2,024,000, bids due 24 Nov 2026.